Robert Day

10.4k total citations · 1 hit paper
166 papers, 8.5k citations indexed

About

Robert Day is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Robert Day has authored 166 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 41 papers in Oncology and 36 papers in Cell Biology. Recurrent topics in Robert Day's work include Peptidase Inhibition and Analysis (37 papers), Cellular transport and secretion (28 papers) and Neuropeptides and Animal Physiology (25 papers). Robert Day is often cited by papers focused on Peptidase Inhibition and Analysis (37 papers), Cellular transport and secretion (28 papers) and Neuropeptides and Animal Physiology (25 papers). Robert Day collaborates with scholars based in Canada, United States and France. Robert Day's co-authors include Nabil G. Seidah, Michel Chrétien, Michel Salzet, Martin Fugère, Isabelle Fournier, Suzanne Benjannet, Roxane Desjardins, Normand Rondeau, Pierre J. Talbot and Josée Hamelin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Robert Day

165 papers receiving 8.3k citations

Hit Papers

PC1 and PC2 are proprotei... 1991 2026 2002 2014 1991 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Day 4.2k 1.8k 1.3k 1.1k 1.0k 166 8.5k
Thomas Wieland 6.5k 1.6× 1.2k 0.7× 1.2k 0.9× 657 0.6× 839 0.8× 253 10.2k
Claude Lazure 4.0k 1.0× 1.6k 0.9× 1.4k 1.1× 1.1k 1.0× 1.0k 1.0× 163 8.2k
Daniela Rotin 10.0k 2.4× 2.1k 1.2× 1.2k 0.9× 1.8k 1.7× 829 0.8× 125 13.0k
Christer Wernstedt 6.1k 1.5× 995 0.6× 865 0.7× 1.5k 1.4× 1.2k 1.2× 85 9.5k
Christoph Thiele 6.8k 1.6× 2.7k 1.5× 748 0.6× 719 0.7× 1.6k 1.5× 115 10.6k
Timothy Haystead 8.5k 2.1× 1.9k 1.1× 608 0.5× 800 0.7× 392 0.4× 170 11.7k
Michael J. Comb 8.6k 2.1× 1.2k 0.7× 2.1k 1.6× 1.6k 1.4× 377 0.4× 76 11.3k
L T Williams 7.2k 1.7× 1.8k 1.0× 1.1k 0.9× 1.2k 1.2× 857 0.8× 65 10.2k
Thomas A. Neubert 7.1k 1.7× 1.8k 1.0× 1.7k 1.3× 720 0.7× 434 0.4× 191 10.4k
Jeroen Demmers 8.8k 2.1× 2.4k 1.4× 1.2k 0.9× 951 0.9× 401 0.4× 203 13.3k

Countries citing papers authored by Robert Day

Since Specialization
Citations

This map shows the geographic impact of Robert Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Day more than expected).

Fields of papers citing papers by Robert Day

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Day. The network helps show where Robert Day may publish in the future.

Co-authorship network of co-authors of Robert Day

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Day. A scholar is included among the top collaborators of Robert Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Day. Robert Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwiatkowska, Anna, et al.. (2023). Enhancing the Drug-Like Profile of a Potent Peptide PACE4 Inhibitor by the Formation of a Host–Guest Inclusion Complex with β-Cyclodextrin. Molecular Pharmaceutics. 20(9). 4559–4573. 2 indexed citations
2.
Evagelidis, Alexandra, Johann Guillemot, Emilia Sikorska, et al.. (2020). The motif EXEXXXL in the cytosolic tail of the secretory human proprotein convertase PC7 regulates its trafficking and cleavage activity. Journal of Biological Chemistry. 295(7). 2068–2083. 6 indexed citations
3.
Gagnon, Hugo, et al.. (2020). Mast Cell Degranulation Increases Mouse Mast Cell Protease 4–Dependent Vasopressor Responses to Big Endothelin-1 But Not Angiotensin I. Journal of Pharmacology and Experimental Therapeutics. 376(2). 213–221. 3 indexed citations
4.
Houde, M, Adel Schwertani, Roger Lecomte, et al.. (2018). Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction. Frontiers in Pharmacology. 9. 868–868. 13 indexed citations
5.
Couture, Frédéric, Robert Sabbagh, Anna Kwiatkowska, et al.. (2017). PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer. Cancer Research. 77(24). 6863–6879. 35 indexed citations
6.
Essalmani, Rachid, Delia Susan‐Resiga, Johann Guillemot, et al.. (2017). Thrombin activation of protein C requires prior processing by a liver proprotein convertase. Journal of Biological Chemistry. 292(25). 10564–10573. 7 indexed citations
7.
Lu, Yinghui, Kornelia Hardes, Boris Strehlow, et al.. (2012). Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases. Journal of Biological Chemistry. 287(26). 21992–22003. 93 indexed citations
8.
Longuespée, Rémi, Annie Desmons, D. Vinatier, et al.. (2012). Ovarian cancer molecular pathology. Cancer and Metastasis Reviews. 31(3-4). 713–732. 50 indexed citations
9.
Longuespée, Rémi, Annie Desmons, Olivier Kerdraon, et al.. (2012). The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling. Histochemistry and Cell Biology. 138(1). 141–154. 27 indexed citations
10.
Gagnon, Sandra, Hugo Gagnon, Roxane Desjardins, et al.. (2012). Disruption of Proprotein Convertase 1/3 (PC1/3) Expression in Mice Causes Innate Immune Defects and Uncontrolled Cytokine Secretion. Journal of Biological Chemistry. 287(18). 14703–14717. 33 indexed citations
11.
Couture, Frédéric, François D’Anjou, & Robert Day. (2011). On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications. BioMolecular Concepts. 2(5). 421–438. 55 indexed citations
12.
D’Anjou, François, Sophie Routhier, Jean‐Pierre Perreault, et al.. (2011). Molecular Validation of PACE4 as a Target in Prostate Cancer. Translational Oncology. 4(3). 157–IN9. 58 indexed citations
13.
Susan‐Resiga, Delia, Rachid Essalmani, Josée Hamelin, et al.. (2011). Furin Is the Major Processing Enzyme of the Cardiac-specific Growth Factor Bone Morphogenetic Protein 10. Journal of Biological Chemistry. 286(26). 22785–22794. 50 indexed citations
14.
Wardman, Jonathan H., Xin Zhang, Sandra Gagnon, et al.. (2010). Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. Journal of Neurochemistry. 114(1). 215–225. 60 indexed citations
15.
Bergeron, François, Richard Leduc, & Robert Day. (2000). Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications. Journal of Molecular Endocrinology. 24(1). 1–22. 158 indexed citations
16.
Hörsch, Dieter, Robert Day, Nabil G. Seidah, Eberhard Weihe, & Martin Schäfer. (1997). Immunohistochemical Localization of the Pro-Peptide Processing Enzymes PC1/PC3 and PC2 in the Human Anal Canal. Peptides. 18(5). 755–760. 7 indexed citations
17.
Day, Robert, et al.. (1994). Gene Organization of the Mouse Pro-Hormone and Pro-Protein Convertase PC1. DNA and Cell Biology. 13(4). 395–407. 42 indexed citations
18.
Konings, Pierre N.M., Barbara Mania‐Farnell, Margery C. Beinfeld, et al.. (1993). Processing, release and metabolism of cholecystokinin in SK-N-MCIXC cells. Neuropeptides. 25(1). 19–30. 8 indexed citations
19.
Keith, Ingegerd M., Robert Day, Simon Lemaire, & Irma Lemaire. (1987). Asbestos-Induced Fibrosis in Rats: Increase in Lung Mast Cells and Autacoid Contents. Experimental Lung Research. 13(3). 311–327. 23 indexed citations
20.
Day, Robert, Simon Lemaire, Denis Nadeau, Ingegerd M. Keith, & Irma Lemaire. (1987). Changes in Autacoid and Neuropeptide Contents of Lung Cells in Asbestos-induced Pulmonary Fibrosis. American Review of Respiratory Disease. 136(4). 908–915. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026